NCT03976739 Study on the Effect of Bile Reflux on Gastric Cancer and Its Precancerous Lesions: a Cross-sectional Study. Status COMPLETED Phase N/A
NCT03972956 Samples Procurement for Colorectal Cancer, Gastric Cancer, and Non-malignant Disease Status RECRUITING Phase N/A
NCT03961867 Docetaxel Versus Oxaliplatin as Addition to S-1 for Stage II / III Gastric Adenocarcinoma Status UNKNOWN Phase PHASE3
NCT03960775 The Influence of Perioperative Administration of Dexmedetomidine on Inflammation Response and Postoperative Recovery in Patients Undergoing Robot or Laparoscopic Assisted Gastrectomy Status COMPLETED Phase NA
NCT03960060 A Study of CCT301-59 CAR T Therapy in Adult Subjects With Recurrent or Refractory Solid Tumors Status TERMINATED Phase PHASE1
NCT03959293 Clinical Trial Evaluating FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab and Tremelimumab in Second-line Treatment of Patients With Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03958032 Effects of Sarcopenia on Early Postoperative Outcomes in Patients Undergoing Surgical Treatment for Gastric Cancer Status COMPLETED Phase N/A
NCT03958019 Rehabilitation Strategies Following Oesophagogastric and Hepatopancreaticobiliary Cancer Status UNKNOWN Phase NA
NCT03957564 Liquid Biopsy in Monitoring the Neoadjuvant Chemotherapy and Operation in Gastric Cancer Status UNKNOWN Phase PHASE2
NCT03957486 Effect of Arterial Cannulation on the Continuous and Non-invasive Hemoglobin Monitoring Status COMPLETED Phase NA
NCT03952442 Nutrition Education Program for Postoperative Patients With Gastric Cancer Status UNKNOWN Phase NA
NCT03950271 SHR-1210 Combined With Trastuzumab , Oxaliplatin and Capecitabine for Neoadjuvant Therapy of Gastric Adenocarcinoma/Gastroesophageal Junction Adenocarcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03941626 Autologous CAR-T/TCR-T Cell Immunotherapy for Solid Malignancies Status UNKNOWN Phase PHASE1/PHASE2
NCT03941561 S-1 for 9 Months Versus 1 Year for Stage II Gastric Cancer (SMAC) Status RECRUITING Phase PHASE3
NCT03939962 Camrelizumab Combined With FOLFOX Neoadjuvant Therapy for Resectable Gastric and Gastroesophageal Junctional Adenocarcinoma Status UNKNOWN Phase PHASE2
NCT03935893 Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03924466 Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients Status RECRUITING Phase PHASE2